- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Crohn disease
- Meeting Date: March 2024
- Public Summary Document (PSD) March 2024 PBAC Meeting - (PDF 3.2MB)
- Public Summary Document (PSD) March 2024 PBAC Meeting - (Word 481KB)
Budesonide – March 2024
Budesonide: Capsule (enteric) 3 mg; Budenofalk®
Last updated
30 May 2025